secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENXBIO Inc. (RGNX)
CIK:        0001590877
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0000950170-24-068050
Event type: other_material
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

REGENXBIO annual meeting voting results; all three director nominees elected, auditor ratified, say-on-pay approved
--------------------------------------------------------------------------------

- George Migausky, Kenneth T. Mills, David C. Stump elected as Class III directors with 39.1M, 39.3M, and 35.0M votes for, respectively.
- Ratification of PricewaterhouseCoopers as auditor for FY2024: 44.2M for, 58K against, 41K abstain.
- Advisory approval of named executive officer compensation: 40.1M for, 727K against, 35K abstain, with 3.3M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590877/000095017024068050/0000950170-24-068050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590877/000095017024068050/rgnx-20240531.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-068050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer